PRESTRELSKI STEVEN

PrivateCIK: 1744027
Location

CHICAGO, IL

PRESTRELSKI STEVEN (Chief Scientific Officer) received a stock award from XERIS BIOPHARMA HOLDINGS, INC.

Compensation award — not an open‑market transaction. Less informative as a directional signal.

A · 2 awards
InsiderPRESTRELSKI STEVENCIK 1744027
Officer· Chief Scientific Officer
Since Oct 2021
+609.38K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
8
Total transactions
609.38K acquired
Non-Derivative Transactions2

Common Stock

Direct
A · Award

Shares

+384.78K

Price / share

Trade value

% of position

New position
10/5/2021
0.00384.78K

Common Stock

Direct
A · Award

Shares

+110K

Price / share

Trade value

% of position

28.6%
10/5/2021
384.78K494.78K
Total

Net shares

+494.78K

Net value

$0.00

Derivative Transactions6

Stock Option (Right to Buy)

Direct
A · Award
Converts to

Common Stock

11.23K shares

Shares

+11.23K

Strike price

0.69

Held after

11.23K

Exercisable

10/5/2021

Stock Option (Right to Buy)

Direct
A · Award
Converts to

Common Stock

28.07K shares

Shares

+28.07K

Strike price

1.55

Held after

28.07K

Exercisable

10/5/2021

Stock Option (Right to Buy)

Direct
A · Award
Converts to

Common Stock

11.27K shares

Shares

+11.27K

Strike price

1.55

Held after

11.27K

Exercisable

10/5/2021

Stock Option (Right to Buy)

Direct
A · Award
Converts to

Common Stock

14.04K shares

Shares

+14.04K

Strike price

5.93

Held after

14.04K

Exercisable

10/5/2021

Stock Option (Right to Buy)

Direct
A · Award
Converts to

Common Stock

25K shares

Shares

+25K

Strike price

13.88

Held after

25K

Exercisable

10/5/2021

Stock Option (Right to Buy)

Direct
A · Award
Converts to

Common Stock

25K shares

Shares

+25K

Strike price

3.94

Held after

25K

Exercisable

10/5/2021
PRESTRELSKI STEVEN — Insider Transaction (Form 4) Filed Oct 5, 2021 | Finecho